Actively Recruiting
Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies
Led by Centre Hospitalier Intercommunal Robert Ballanger · Updated on 2024-07-15
214
Participants Needed
2
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.
CONDITIONS
Official Title
Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Scheduled for major urological surgery such as cystectomy, nephrectomy, or other laparotomies
- Provided free and informed consent to participate
- Affiliated with a social security scheme
You will not qualify if you...
- Immune deficiency including HIV infection
- Surgery performed urgently
- Curative surgery for chronic urinary tract infection
- Unable to take Oral Impact® for 7 days before surgery
- Unstable psychiatric condition
- Infection with COVID-19 during postoperative stay
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CHI Robert Ballanger
Aulnay-sous-Bois, France, 93600
Actively Recruiting
2
CHI André Grégoire
Montreuil, France, 93100
Actively Recruiting
Research Team
S
Serge Ndoko, MD
CONTACT
S
Sabrina Lassouani, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here